A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection

Clinical trial NCT05137717 · COMPLETED

Trial details

NCT number: NCT05137717
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus (CMV)

Start date: 2022-01-18
Primary completion: 2023-06-27
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.